Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.58 |
| ▸ | ACHE | P22303 | 3/20 | 0.58 |
| ▸ | ODC1 | P11926 | 2/20 | 0.58 |
| ▸ | BACE1 | P56817 | 2/20 | 0.58 |
| ▸ | BCHE | P06276 | 1/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | APP | P05067 | 2/20 | 0.50 |
| ▸ | HRH1 | P35367 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | HIF1AN | Q9NWT6 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lespeol SCHEMBL5522457 | 0.92 | PTPN1 (0.69) | PTPN1ACHEODC1BACE1BCHE | |
| SCHEMBL23860681 | 0.85 | PTPN1 (0.59) | PTPN1ACHEBACE1SLC6A2APP | |
| SCHEMBL30229516 | 0.85 | PTPN1 (0.59) | PTPN1ACHEBACE1SLC6A2APP | |
| Lonchocarpin SCHEMBL29435870 | 0.82 | PTPN1 (0.83) | PTPN1ACHEODC1BACE1BCHE | |
| SCHEMBL5522452 | 0.82 | PTPN1 (0.72) | PTPN1ACHEODC1BACE1BCHE | |
| SCHEMBL29775511 | 0.77 | PTPN1 (0.51) | PTPN1ACHEODC1BACE1BCHE | |
| SCHEMBL30557973 | 0.76 | PTPN1 (0.45) | PTPN1BCHESLC6A2APPHRH1 | |
| SCHEMBL31545683 | 0.75 | SLC6A2 (0.62) | PTPN1ACHEBACE1BCHESLC6A2 | |
| SCHEMBL16244637 | 0.74 | ALOX5 (0.55) | PTPN1ACHEODC1BACE1BCHE | |
| SCHEMBL16244639 | 0.74 | ALOX5 (0.55) | PTPN1ACHEODC1BACE1BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569530-B2 | Tannin-based antiproliferative pharmaceutical | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-03-10 | — | — | US | disclosed |
| US-12453799-B1 | Bioadhesive for medical and dental applications | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2025-10-28 | — | — | US | disclosed |
| US-20250249063-A1 | METHOD FOR TREATING ORAL CANCER | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-08-07 | — | — | US | disclosed |
| US-12318422-B2 | Tannin-based antiproliferative pharmaceutical | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-06-03 | — | — | US | disclosed |
| US-20240293492-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-09-05 | — | — | US | disclosed |
| US-20230210931-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-07-06 | — | — | US | disclosed |
| US-11376570-B1 | Method of forming copper oxide-on-copper nanomaterial catalyst mesh | KING ABDULAZIZ UNIVERSITY (SA) | 2022-07-05 | — | — | US | disclosed |
| US-11311492-B1 | Carbon nanomedicine with natural ligands | KING ABDULAZIZ UNIVERSITY (SA) | 2022-04-26 | — | — | US | disclosed |
| US-11234940-B1 | Method for making a noble metal nanomedicine | KING ABDULAZIZ UNIVERSITY (SA) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250249063-A1 | METHOD FOR TREATING ORAL CANCER | UGGT1, G6PD, UGT1A3 | PTPN1 978/4885ACHE 1689/4885ODC1 3826/4885 |
| US-20240293492-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | UGGT1, G6PD, UGDH | PTPN1 932/4885ACHE 2858/4885ODC1 3907/4885 |
| US-12569530-B2 | Tannin-based antiproliferative pharmaceutical | SLC2A3, SLC2A1, SLC2A8 | PTPN1 1000/4885ACHE 1682/4885ODC1 3568/4885 |
| US-20230210931-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | UGGT1, G6PD, UGDH | PTPN1 932/4885ACHE 2858/4885ODC1 3907/4885 |
| US-12318422-B2 | Tannin-based antiproliferative pharmaceutical | UGGT1, G6PD, UGDH | PTPN1 932/4885ACHE 2858/4885ODC1 3907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.